Kristin Macey

Ms. Kristin Macey


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
SHSean M. Hays
Sean M. Hays
KMKristin Macey
Kristin Macey
ANAndy Nong
Andy Nong
LALesa L. Aylward
Lesa L. Aylward

1 June 2016 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
SHSean M. Hays
Sean M. Hays
KMKristin Macey
Kristin Macey
DPDevika Poddalgoda
Devika Poddalgoda
MLMing Lu
Ming Lu
ANAndy Nong
Andy Nong
LALesa L. Aylward
Lesa L. Aylward

1 February 2014 in Environment International
Verified
Journal Article
Open access
DRDorothea F.K. Rawn
Dorothea F.K. Rawn
JRJ. Jake Ryan
J. Jake Ryan
ASAmy R. Sadler
Amy R. Sadler
WSWing-Fung Sun
Wing-Fung Sun
DWDorcas Weber
Dorcas Weber
JOJay Van Oostdam
Jay Van Oostdam
Pooling of surplus serum from individual samples, collected between 2007 and 2009 during Cycle 1 of the Canadian Health Measures Survey (CHMS), was performed to develop a national baseline estimate of brominated flame retardants in Canadians. Serum samples were categorized by sex and distributed by five age groups ranging from 6 to 79years. Nearly 5000 (4583) serum samples were used to form 59 composite pools. Serum pools were created to ensure a high detection frequency of these analytes in serum because low volume samples had previously resulted in non-detectable concentrations. The analytes of interest in these serum pools included 23 polybrominated diphenyl ethers (PBDEs) and three hexabromocyclododecane (HBCD) isomers (α-, β- and γ-HBCD). PBDEs were observed in all samples tested and total PBDE concentrations ranged from 27ngg(-1) lipid to 130ngg(-1) lipid (geometric mean [GM] 46ngg(-1) lipid). ∑PBDE concentrations were significantly elevated in samples representing the 6-11year old age group (GM 65ngg(-1) lipid) relative to ages above 40years, although no difference in concentration was observed between the sexes. PBDE concentrations in Canadian sera from the general population were higher than reported in Europe and Asia, but a little lower than observed in the US. PBDE 47 was the greatest contributor to ∑PBDE concentrations and the GM concentration for this congener was 22ngg(-1) lipid. The other dominant contributors to ∑PBDE concentrations were in descending order: 153 [GM 9.4ngg(-1) lipid]>99 [GM 4.6ngg(-1) lipid]≅100 [GM 4.1ngg(-1) lipid]>209 [GM 1.1ngg(-1) lipid] and 183 [GM 0.42ngg(-1) lipid]. ∑HBCD was detected in all samples analysed, although most samples were observed at concentrations <1ngg(-1) lipid, similar to global concentrations. α-HBCD was the dominant contributor to ∑HBCD concentrations in Canadians although β- and γ-HBCD were detected in 23% and 35% of the samples, respectively. No differences in ∑HBCD concentration were associated with age or sex. This dataset represents the first national data describing HBCD isomers and some PBDEs (e.g., 183, 209) in Canadians.

1 June 2017 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
DPDevika Poddalgoda
Devika Poddalgoda
KMKristin Macey
Kristin Macey
HAHenry Assad
Henry Assad
KKKannan Krishnan
Kannan Krishnan
The objectives of the present work were: (1) to assemble population-level biomonitoring data to identify the concentrations of urinary and plasma barium across the general population; and (2) to derive biomonitoring equivalents (BEs) for barium in urine and plasma in order to facilitate the interpretation of barium concentrations in the biological matrices. In population level biomonitoring studies, barium has been measured in urine in the U.S. (NHANES study), but no such data on plasma barium levels were identified. The BE values for plasma and urine were derived from U.S. EPA's reference dose (RfD) of 0.2 mg/kg bw/d, based on a lower confidence limit on the benchmark dose (BMDL05) of 63 mg/kg bw/d. The plasma BE (9 μg Ba/L) was derived by regression analysis of the near-steady-state plasma concentrations associated with the administered doses in animals exposed to barium chloride dihydrate in drinking water for 2-years in a NTP study. Using a human urinary excretion fraction of 0.023, a BE for urinary barium (0.19 mg/L or 0.25 mg/g creatinine) was derived for US EPA's RfD. The median and the 95th percentile barium urine concentrations of the general population in U.S. are below the BE determined in this study, indicating that the population exposure to inorganic barium is expected to be below the exposure guidance value of 0.2 mg/kg bw/d.

1 March 2017 in International Journal of Hygiene and Environmental Health
Verified
Journal Article
Closed access
AZAngelika Zidek
Angelika Zidek
KMKristin Macey
Kristin Macey
LMLeona MacKinnon
Leona MacKinnon
MPMikin Patel
Mikin Patel
DPDevika Poddalgoda
Devika Poddalgoda
YZYi Zhang
Yi Zhang

1 October 2012 in Environment International
Verified
Journal Article
Closed access
DRDorothea F.K. Rawn
Dorothea F.K. Rawn
JRJ. Jake Ryan
J. Jake Ryan
ASAmy R. Sadler
Amy R. Sadler
WSWing-Fung Sun
Wing-Fung Sun
DHDouglas Haines
Douglas Haines
JOJay Van Oostdam
Jay Van Oostdam